Cargando…
Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target
Severe COVID-19 is characterized by acute respiratory distress syndrome (ARDS)-like hyperinflammation and endothelial dysfunction, that can lead to respiratory and multi organ failure and death. Interstitial lung diseases (ILD) and pulmonary fibrosis confer an increased risk for severe disease, whil...
Autores principales: | Ntatsoulis, Konstantinos, Karampitsakos, Theodoros, Tsitoura, Eliza, Stylianaki, Elli-Anna, Matralis, Alexios N., Tzouvelekis, Argyrios, Antoniou, Katerina, Aidinis, Vassilis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522582/ https://www.ncbi.nlm.nih.gov/pubmed/34671341 http://dx.doi.org/10.3389/fimmu.2021.687397 |
Ejemplares similares
-
Increased lipocalin-2 expression in pulmonary inflammation and fibrosis
por: Galaris, Apostolos, et al.
Publicado: (2023) -
Structure-Based Discovery of Novel Chemical Classes of Autotaxin Inhibitors
por: Magkrioti, Christiana, et al.
Publicado: (2020) -
Autotaxin in Pathophysiology and Pulmonary Fibrosis
por: Ninou, Ioanna, et al.
Publicado: (2018) -
Increased Autotaxin Levels in Severe COVID-19, Correlating with IL-6 Levels, Endothelial Dysfunction Biomarkers, and Impaired Functions of Dendritic Cells
por: Nikitopoulou, Ioanna, et al.
Publicado: (2021) -
Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyrios, et al.
Publicado: (2018)